StimCell Energetics Inc.

STME

US15115X2062

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:42:43 2025-02-14 pm EST			5-day change	1st Jan Change
0.1675 ^USD	+9.12%		-65.10%	-65.81%

Jan. 14	StimCell Energetics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024	CI
Jan. 08	StimCell Energetics Inc. Signs Marketing Agreement with Think Ink Marketing Data & Email Services, Inc	CI

Cell MedX Corp has Changed its Name to StimCell Energetics Inc

November 05, 2024 at 12:00 am EST

On November 05, 2024, Cell MedX Corp changed its name to StimCell Energetics Inc.

Latest news about StimCell Energetics Inc.

StimCell Energetics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024	Jan. 14	CI
StimCell Energetics Inc. Signs Marketing Agreement with Think Ink Marketing Data & Email Services, Inc	Jan. 08	CI
Cell MedX Corp has Changed its Name to StimCell Energetics Inc	Nov. 05	CI
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2024	24-10-15	CI
Cell MedX Corp. Reports Earnings Results for the Full Year Ended May 31, 2024	24-08-29	CI
StimCell Energetics Inc. Auditor Raises 'Going Concern' Doubt	24-08-28	CI
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	24-04-15	CI
Cell MedX Corp. announced that it has received $0.075 million in funding	24-03-11	CI
Cell Medx Corp. Announces Resignation of Brad Hargreaves from the Board of Directors	24-02-27	CI
Cell MedX Corp. Appoints George Adams as Chairman of the Board	24-02-25	CI
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	24-01-16	CI
Cell MedX Corp. Announces Chief Executive Officer Changes	23-12-19	CI
Cell MedX Corp. Announces Board Appointments	23-12-19	CI
Cell MedX Corp. Announces Board Changes	23-11-09	CI
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-16	CI
Cell MedX Corp. Reports Earnings Results for the Full Year Ended May 31, 2023	23-09-01	CI
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	23-06-29	CI
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	23-05-19	CI
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2022	23-04-19	CI
Cell MedX Corp. Reports Earnings Results for the Full Year Ended May 31, 2022	23-04-07	CI
Cell MedX Corp. Auditor Raises 'Going Concern' Doubt	23-04-06	CI
Cell MedX Corp. Appoints Dwayne Yaretz as Chief Executive Officer Replacing Frank McEnulty	22-04-27	CI
Cell Medx Corp Appoints Dwayne Yaretz to the Board of Directors	22-04-27	CI
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	22-04-11	CI
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	22-01-12	CI

Chart StimCell Energetics Inc.

Duration

Period

STME: Dynamic Chart

StimCell Enegetics Inc., formerly Cell MedX Corp., is a development stage electroceutical medical device company. The Companyâs products include eBalance, and Bio Feedback. The eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms. The biofeedback mechanism is where eBalance offering users and health professionals alike a real-time snapshot of cellular vitality. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling. Microcurrent is a clinically tested therapy treatment used to treat a range of conditions. There is compelling research in diabetes care, wound therapy, migraine treatment, chronic obstructive pulmonary disease (COPD), and anti-ageing.

Employees

Sector

Biotechnology & Medical Research

More about the company